Before using Duaklir Pressair, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.
Duaklir Pressair is a prescription inhaler used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). It contains two long-acting bronchodilators that work together to relax the muscles around your airways, improve airflow, and make breathing easier.
Although Duaklir Pressair can help control COPD symptoms, it may cause side effects or worsen certain medical conditions.
It is important to follow your prescribed treatment schedule and inform your healthcare provider about any changes in your health.
Allergic Reactions and Hypersensitivity
Do not use Duaklir Pressair if you are allergic to aclidinium bromide, formoterol fumarate, or any other ingredient in the medication.
Duaklir Pressair contains lactose, which may contain small amounts of milk proteins. People with a severe allergy to milk proteins should not use this inhaler.
An allergic reaction may cause itching, hives, a skin rash, swelling, or difficulty breathing.
In rare cases, a severe allergic reaction called anaphylaxis may occur. This can cause sudden breathing difficulties, dizziness, or swelling of your face, lips, tongue, or throat.
Stop using Duaklir Pressair and seek emergency medical attention if you experience signs of a serious allergic reaction.
Tell your healthcare provider if you have previously experienced an allergic reaction to other inhaled medications or dry powder inhalers.
Cardiovascular Disorders
Duaklir Pressair should be used cautiously if you have a history of heart disease or other cardiovascular problems.
One of its active ingredients, formoterol fumarate, belongs to a group of medications called long-acting beta2-agonists (LABAs). These medications help relax airway muscles but may also affect your heart rate and blood pressure.
Tell your healthcare provider if you have:
- Hypertension: High blood pressure that may require monitoring during treatment.
- Coronary artery disease: A condition in which narrowed blood vessels reduce blood flow to the heart.
- Cardiac arrhythmias: Irregular heart rhythms that may cause palpitations, dizziness, or a racing heartbeat.
- Other heart conditions: Including a history of heart attack, heart failure, or significant cardiovascular disease.
Duaklir Pressair may occasionally cause a faster heartbeat, palpitations, or changes in blood pressure.
Your healthcare provider may recommend monitoring your blood pressure and heart rate, particularly when you first begin treatment.
Contact your healthcare provider if you experience a persistent racing heartbeat, unusual palpitations, or increased dizziness.
Seek emergency medical attention if you develop chest pain, fainting, or severe breathing difficulties.
Use With Other Anticholinergic Medications
Duaklir Pressair contains aclidinium bromide, a long-acting anticholinergic medication that helps keep your airways open.
Using Duaklir Pressair with other anticholinergic medications may increase your risk of side effects.
These medications can have similar effects on different parts of your body, potentially causing dry mouth, constipation, blurred vision, difficulty urinating, or increased pressure inside the eyes.
Examples of other inhaled anticholinergic medications include tiotropium, ipratropium, and umeclidinium.
Tell your healthcare provider if you use other inhalers or medications containing anticholinergic ingredients.
Do not combine Duaklir Pressair with another anticholinergic inhaler unless your healthcare provider has specifically reviewed your treatment plan.
Your healthcare provider can determine whether your medications are appropriate together and help prevent unnecessary duplication of treatment.
Narrow-Angle Glaucoma
Use Duaklir Pressair cautiously if you have narrow-angle glaucoma or are at risk of developing this condition.
Narrow-angle glaucoma occurs when fluid cannot drain properly from the eye, causing pressure inside the eye to increase.
Aclidinium bromide, one of the active ingredients in Duaklir Pressair, has anticholinergic effects that may worsen narrow-angle glaucoma in susceptible individuals.
Although the medication is inhaled into your lungs, some of it may affect other parts of your body.
Symptoms of an acute narrow-angle glaucoma attack may include severe eye pain, redness, blurred vision, seeing halos around lights, headache, nausea, or vomiting.
Seek emergency medical attention immediately if you develop these symptoms while using Duaklir Pressair.
Tell your healthcare provider if you have glaucoma or a history of increased eye pressure before starting treatment.
Urinary Retention
Duaklir Pressair may cause or worsen urinary retention, a condition in which your bladder cannot empty properly.
This side effect is related to aclidinium bromide, which has anticholinergic effects.
People with an enlarged prostate, also called benign prostatic hyperplasia (BPH), or bladder-neck obstruction may have a higher risk of developing urinary problems during treatment.
Tell your healthcare provider if you have a history of difficulty urinating, an enlarged prostate, or other bladder conditions.
Symptoms of urinary retention may include difficulty starting urination, a weak urine stream, frequent urges to urinate, or a feeling that your bladder has not emptied completely.
Contact your healthcare provider promptly if you notice new or worsening urinary symptoms.
If you are unable to urinate or develop severe lower abdominal pain, seek urgent medical attention.
Low Potassium Levels (Hypokalemia)
Duaklir Pressair may occasionally cause a decrease in potassium levels in your blood. This condition is called hypokalemia.
Potassium is an important mineral that helps your muscles, nerves, and heart function properly. Having too little potassium can affect muscle strength and, in more serious cases, interfere with your heart’s normal rhythm.
Formoterol fumarate, one of the active ingredients in Duaklir Pressair, may temporarily lower blood potassium levels. This effect is uncommon at prescribed doses but may be more significant in people with certain medical conditions or those taking medications that also lower potassium.
Possible symptoms of low potassium include:
- Muscle weakness: You may experience unusual weakness, muscle cramps, or fatigue.
- Heart palpitations: You may notice a racing, pounding, or irregular heartbeat.
- Dizziness: You may feel lightheaded or unusually weak.
- Muscle spasms: You may experience unexpected muscle twitching or cramping.
The risk may be higher if you take certain diuretics, also called water pills, particularly those that increase potassium loss.
Tell your healthcare provider if you have a history of low potassium levels, heart rhythm problems, or take medications that affect your body’s electrolyte balance.
Your healthcare provider may recommend blood tests to check your potassium levels if you have additional risk factors.
Contact your healthcare provider if you experience persistent muscle weakness, unusual cramping, or heart palpitations. Seek emergency medical attention if you develop fainting, chest pain, or a sustained irregular heartbeat accompanied by dizziness.
When to Contact Your Healthcare Provider
Contact your healthcare provider if you experience new or worsening symptoms while using Duaklir Pressair, particularly unusual heart palpitations, difficulty urinating, muscle weakness, or changes in your vision.
You should also seek medical advice if your COPD symptoms become more difficult to control or if you need your rescue inhaler more often than usual.
Seek immediate medical attention if you develop severe eye pain with blurred vision, an inability to urinate accompanied by significant abdominal pain, or signs of a serious allergic reaction.
If your breathing suddenly worsens immediately after using Duaklir Pressair, stop using the inhaler and seek urgent medical attention. This may indicate paradoxical bronchospasm, a rare but potentially serious reaction.
Always use Duaklir Pressair exactly as prescribed. Following your recommended dosage, informing your healthcare provider about other medications, and monitoring unusual symptoms can help you manage COPD while reducing the risk of complications.
REVIEWS